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CHAPTER I 
INTRODUCTION AND LITERATURE REVIEW 
A. LEAD INTOXICATION 
Lead poisoning usually results from the ingestion of lead-contain-
ing substances such as water which has stood in lead pipes, lead-base 
paint, and objects containing lead solder or from the inhalation of 
fumes containing volatilized lead from burning storage batteries. 
Other means which inadvertently lead to lead poisoning include the im-
bibing of illicit ("corn") \vhiskey contaminated by lead solder in the 
pipes of the still or victims surviving gun-shot 1._:rounds who retain the 
embedded pellets (bullets or buckshot) which can cause poisoning many 
years later after entrapment in a serous cavity. As a rule, absorption 
by any route is slow, and prolonged exposure is necessary for the de-
velopment of symptoms. 
According to Bennett and Poskanzer (1970)~ Lead is an example of 
a cumulative poison which is slowly excreted and is almost never seen 
or described as an acute poison. Symptoms develop slowly, but mostly 
after chronic exposure. Lead which is absorbed is deposited in 
bones as elemental lead and is metabolized in a rnanner similar to that 
of calcium. Under such chronic conditions, blood, urine, and feces 
levels are very low. According to the aforementioned physicians, once 
the source of the abnormal absorption of lead has been terminated, 
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virtually all of the lead in the body is directed into bone. They 
finally note that it requires approximately t1.;ice the time to excrete 
a given burden of lead as it does to accumulate it. 
B. BONE REHODELING 
Krook, Shively, Duncan, and Pond (1973) agreed with Whalen, Win-
chester, Krook, Dische, and Nunez (1971) in their observations on lead 
intoxicated animals in regards to the remodeling of bone that the physio-
logical resorption, specifically of metaphyseal trabeculae, occurred 
mainly by osteocytic osteolysis, a pathologic-physiologic process re-
viewed by Belanger (1969). Osteolysis is defined as an internal re-
sorption of bone centered around the activity of deep-seated osteocytes. 
It has been shmm repeatedly by Belanger (1965, 1968, 1970), Belanger, 
Semba, Tolnai, Copp, Krook, and Gries (1966), Brown, Krook, and Pond 
(1966), and Henrikson (1968) that osteolysis is the primary mechanism 
in bone resorption, both under physiologic conditions and in diseases 
characterized by excessive resorption. 
This deep seated bone-resorption has been related by some 
authors to the death of the osteocyte. Most of them have interpreted 
this phenomenon as passive. Pritchard wrote in 1956 ~the osteocyte is 
an essential constituent of bone, for when the cells die, the matrix 
around them, although persisting for a time, eventually crumbles and 
is removed to be replaced by living bone". 
Rutishauser and Majno (1951) have recognized perilacunar resorp-
tion as a result of cellular activity. They called it "physiological 
necrosis". These authors described the phenomenon as occurring "at the 
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center of the trabeculae" in spongy bone and "at the periphery of the 
Haversian systems" in compact bone. The dying cells often show a "split-
ting nucleus" and "reappearance of alkaline phosphatase". 
Whalen, et al., (1971) and Krook, et al., (1973) concluded that 
the initial bone lesion in these animals was the result of the inhibition 
of osteocytic activity resulting in a widening of the trabeculae, even-
tual necrosis of osteocytes with the now dead bone tissue becoming the 
object of osteoclasia. Osteoclasia is a secondary phenomena involved 
in the removal of already altered bone such as occurs in necrosis from 
fractures or from bone altered by osteolysis (Belanger, Semba, Copp, 
Tolnai, Krook, and Gries, 1966). 
C. PARATHYROID HORMONE AND CORTICOSTEROIDS 
While the physiological and pharmacological effects of parathyroid 
hormone (PTH) and hydrocortisone (cortisol) on bone have been documented 
and are thus well known, their precise mechanisms of action remain el-
lusive and have yet to be illucidated after more than three decades of 
intense investigation (Albright and Reifenstein, 1948; Milne, 1951; 
Dent, 1953; Sissons and Hadfield, 1955; Silberberg and Silberberg, 1956; 
Talmage, 1956; Bernick and Ershoff, 1963; Arnaud, 1967; Copp, 1970; 
Burns, 1974; Daughaday, 1975; Guyton, 1976). 
Parathyroid hormone (PTH) controls body fluid calcium levels prin-
cipally by regulating the removal of calcium from bone. After PTH ad-
ministration, marked elevations in plasma calcium levels occur within 
several hours (Talmage, 1969). PTH stimulates osteoclast activity in 
vitro (Holtrop, Raisz, and Simons 1974), increases osteoclast populations 
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in vivo (Tatevossian, 1973), and accelerates the rate of skeletal re-
modeling (Heller, McLean, and Bloom, 1950). 
Systemically, corticosteroids affects a wide variety of metabolic 
processes. The deleterious affect they have on bone (Winter, Silberberg, 
and Stoerk, 1950; Follis, 1951; Sissons and Hadfield_ 1955; Silberberg 
and Silberberg, 1956; Laron, Muhlethaller, and Klein~ 1958; Bernick and 
Ershoff, 1963), ground substance (Seifter, Ehrich, ~oeder, ~uth, and 
Hauser, 1953; Sobel, Gabay, and Johnson, 1958), and fibroblastic activ-
ity (Baker and Whitaker, 1950; Sissons and Hadfield, 1951; Gerarde and 
Jones, 1953), and their inhibition of the inflammatory reaction are 
well documented. 
Roberts in 1969 and Kenner in 1970 found that the effect of cor-
tisol on bone is dose and time dependent. Low doses of cortisol (1-5 
mg/kg/day)stimulate bone resorption and high doses of cortisol (20-75 
mg/kg/day) inhibit bone resorption. The low doses of cortisol reduced 
the bone volume by ~ncreasing the number of osteoclasts and decreasing 
the number of osteoblasts. Over a long time period any dosage over 
2.0 mg/kg/day inhibits bone resorption (Roberts, 1969). In these ex-
periments Roberts also noted that at low doses the corticosteroid ac-
tion is characterized by increased progenitor cell proliferation, in-
creased number of osteoclasts, and increased resorption of alveolar 
bone. At the higher dose levels, progenitor cell proliferation and 
bone formation were depressed without any evidence of increased re-
sorption of the alveolar bone, These findings suggest two antagonistic 
mechanisms; 1) direct inhibition of progenitor cell proliferation by 
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cortisol and 2) inducement of a secondary hyperparathyroidism by corti-
sol which results in increased bone resorption. 
Corticosteroids reduce serum calcium levels and also have an anti-
proliferative action on cells. It has been suggested that the increased 
numbers of precursor cells and osteoclasts is a result of the increase 
in PTH secretion (Talmage, 1969) caused by the lowered serum calcium 
after the administration of cortisol (Storry, 1960; Stoerk, Peterson, 
and Jelinek, 1963; Gordan, Hansen, and Lubick, 1967; Rasmussen, 1968). 
Roberts also states that the high dose levels of corticosteroid 
blocks the parathyroid mediated effect (the increased osteoclasts and 
bone resorption) by inhibiting parathyroid hormone-stimulated prolifer-
ation of fibroblasts. It is also possible that high doses of cortisol 
could act directly upon the parathyroid glands and depress the secre-
tion of PTH. 
In an early study of the interrelationship between cortisone and 
parathyroid extract in rats, Laron, Muhlethaler, and Klein (1958) gen-
erally summarized that an excess of parathyroid hormone caused changes 
in teeth and bone, and it also induced hypercalcemia and nephrocalcin-
osis. They further stated that cortisol also produced changes in bone, 
but those changes manifested were different from those induced by an 
excess of parathyroid hormone. Cortisol produces hypercalcuria without 
causing hypercalcemia, and, according to Pincus, Natelson, and Lugovoy 
(1951), it may even reduce normal concentrations of serum calcium; it 
has been used to reduce elevated serum calcium levels in hypervitamino-
sis D (vitamin D poisoning), infantile hypercalcemia, and sarcoidosis. 
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On the other hand, Dent (1956) claimed that cortisone was ineffective 
in lowering the hypercalcemia of hyperparathyroidism in man. 
Parathyroid hormone is a polypeptide with a molecular weight of 
approximately 8500 whose main and perhaps only function is the mainte-
nance of calcium homeostasis. On the other hand, hydrocortisone is 
classified as a steroid with a structural nucleus common to all deriva-
tives of this group: the perhydropentanophenanthreoe structure, with a 
molecular weight of approximately 232.84, being essentially derived 
from a cholesterol precursor (Figures I-1, I-2). 
Unlike parathyroid hormone, whose release is primarily determined 
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by perfusing glandular serum levels of calcium, it is now known that 
cortisone and hydrocortisone are regulated by a series of feedback mechan-
isms involving other endocrine and associated structures: the hypothal-
amus and pituitary gland. The one thing they do have in common is their 
initial reaction with a specific receptor located in the membrane as is 
the case of the former (Rasmussen, 1970, 1971) or in the cytoplasm by 
the latter (Burns, 1974). In both cases, the receptor sites tend to 
have a conformational structure complementary to the structure of the 
hormone allowing it to combine or conjugate to the former with a high 
degree of affinity. It, therefore appears that two major systems exist 
which tend to help explain most hormonal action mec~anisms with the ex-
ception of insulin and thyroid hormone whose effects on metabolic activity 
in practically all cells remain obscure. 
D. MECHANISM OF ACTION OF H0~10NES 
1. Adenyl Cyclase - Cyclic Adenosinemonophosphate System 
Figure l-1 Perhydropentanophenanthrene nucleus 
(completely saturated multicyclic structure). 
Figure I-2 Hydrocortisone (Cortisol) 
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The nucleotide adenosine 3',5'-monophosphate (c-AMP) is now recog-
nized as the key mediator in the action of many processes in the animal 
and plant kingdoms. It was largely through the patient, painstaking 
investigations of Sutherland and his coworkers over the last 20 years, 
summarized in a lecture delivered when he received the Nobel Prize in 
Physiology in Stockholm, Sweden, in December, 1971, that heralded the 
rivalry of c-AMP to adenosinetriphosphate (ATP) in the biological world 
(Sutherland, 1972). Since that time, investigations on the role of 
c-AJW have developed enormously. Not only is c-AMP found in the cells 
of all animal tissues studied, but it has been recently identified in 
bacteria as a necessary element for the induction of ~ertain enzymes. 
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It has also been identified as an attractant substance for such organisms 
as amoeba and the slime mold causing them to aggregate. 
In 1957 Sutherland and Rall reported that cycli~ AMP mediates the 
effects of epinephrine on liver phosphorylase. Subsequent studies 
(Robinson, Butcher, and Sutherland, 1968) have shown that the physiolo-
gical actions of many other hormones and biologically active substances 
such as corticotrophin, thyrotrophin, serotonin~ vasopressin, and lu-
teinizing hormone are also mediated by this nucleotide. Interaction of 
these substances with their respective target cells leads to activation 
of adenyl cyclase, a membrane-bound enzyme that catalyzes the conversion 
of adenosine triphosphate to cyclic AMP. The cycli~ AMP produced affects 
other cellular processes, such as activation, induction, or secretion of 
enzymes, active transport of ions across cellular membranes, or release 
of other hormones. Activation of the particular system involved causes 
the physiological response attributed to the hormone. In many instances 
the intracellular process stimulated by cyclic AMP is still unknown (Aur-
bach, Potts, Chase, and Melson, 1969). 
Parathyroid hormone causes a marked increase in activity of adenyl 
cyclase from renal cortex (Chase and Aurbach, 1968)~ isolated renal cor-
tical tubules (Melson, Chase, and Aurbach, 1968), fetal rat calvaria and 
iliac bone from mature rats (Chase, Fedak, and Aurbach, 1969). Signifi-
cant stimulation of the enzyme can be detected within 15 seconds after 
adding PTH to the test systems previously mentioned. This change is the 
earliest response to PTH that has been observed~ and the enzyme in iso-
lated tubules from renal cortex is sensitive to the hormone at very low 
concentrations (0.05 ~g/ml). 
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Certain hormones activate adenyl cyclase in brain, adrenal, thy-
roid, and skeletal muscle but not in bone and kidney. In contrast, para-
thyroid hormone causes stimulation of the enzyme onLy in the latter tis-
sues (Chase, Fedak, and Aurbach, 1969). Parathyroid hormone affects 
adenyl cyclase only in tissues where it has a known physiological function. 
It is apparent from data presented by Aurba~h, Potts~ Chase, and 
l1elson in 1969 that cyclic AMP is a mediator in the mechanism of action 
of parathyroid hormone and that the metabolic pro~esses leading to the 
observed physiological effects of the hormone on both bone and kidney 
are initiated by a common mechanism: stimulation of adenyl cyclase. The 
exact intracellular metabolic processes affected by cyclic AMP in renal 
and skeletal tissue are unknown. 
The manner in which c-Al~ mediates hormonal activity appears to 
be constant for parathyroid hormone in all mammalian species studied 
so far. It has been dubbed a "second messenger 1'. Visualize PTH as 
the first messenger, circulating in the plasma, encountering and subse-
quently interacting with a specific receptor in the plasma membrane of 
the target cell. The receptor [possibly linked to or an integral part 
of the enzyme adenyl cyclase (AC)], which imparts specificity, interacts 
with PTH, thus activating AC, which in turn catalyzes the formation of 
c-AMP from ATP. The ne\vly formed c-AMP then activates or triggers the 
response characteristic of and recognized as the biological action of 
PTH. As a part of nature's "checks-and-balances", or homeostatic mech-
anism, the activity of c-AHP is regulated by a potent enzyme known as 
phosphodiesterase. This cyclic nucleotide phosphodiesterase, found in 
the particulate and soluble fractions of the cell, catalyzes the hydrol-
ysis of cyclic M1P to adenosine 5 1 -monophosphate. Inhibition of the 
phosphodiesterase also causes increased intracellular concentration of 
cyclic AMP, but so far no hormone has been found to be an inhibitor of 
this enzyme (Aurbach, Potts, Chase, and Melson, 1969). A schematic rep-
resentation of this second messenger may be seen in Figure I-3 (modi-
fied after Sutherland, 1972). 
2. Cytoplasmic Receptor-Nuclear Acceptor Syste~ 
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According to Burns (1974), all of the steroid hormones exert their 
metabolic effects, more or less, through this syste~. Jt is hypothesized 
that these steroids are capable of penetrating the celL mambrane and com-
bining with a highly specific protein receptor in the cytoplasm. This 
conjugated steroid-receptor complex, in turn, is transLocated to the 
Stimulus 
\II 
Parathyroid 
Glands 
,,, 
Released PTH 
(First Messenger) 
~ 
Figure I - 3 Adenyl Cyclase - c-AMP System 
Cell 
Membrane 
Adenyl 
Cyclase 
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(Inactivation of C-AMP 
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I-' 
I-' 
nucleus which enters to then combine with specific acceptors located on 
chromatin. This complex steroid-receptor-acceptor now causes nuclear 
genetic material to produce messenger ribose nucleic acid (m-RNA), which 
now signals and directs the fabrication of some highly specific enzyme 
whose action is directly responsible for producing the physiologic ex-
pression of the hormone's activity. Specificity of this system resides 
in the conformational structure of the receptor protein to the steroid 
hormone and this complex condensing to the nuclear chromatin acceptor. 
This system may be visualized in Figure I-4 (modified after Burns, 1974). 
E. STATEMENT OF THE PROBLEM 
Since a number of investigations (previously cited) have been 
reported where varying doses of PTH and cortisol were used over rather 
extended periods of time it seemed reasonable to conduct a short-term 
study using relatively high doses of the two hormones, but administering 
them at broader time intervals. In other words, all test animals to be 
studied would be already rendered lead-intoxicated before they would be 
·challenged by PTH, cortisol, and a combination of the two, and at some 
subsequent point in time, sacrificed. Bone tissue sections and blood 
samples will be examined in order to determine whether or not any changes 
occurred during the acute experimental period that might parallel those 
of the aforementioned chronic studies. 
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CHAPTER II 
MATERIALS AND METHODS 
A. EXPERIMENTAL ANIMALS 
Twenty-eight, young, adult, male, Sprague-Dawley rats, whose 
weights ranged from 174 to 311 grams, were used in this investigation. 
Upon receipt, the animals were allowed to become acclimated to their 
new environment and fed a normal diet of Purina Fox Chow pellets with 
water allowed ad libitum. 
Following this seven day acclimation period, the animals were 
then maintained on a diet consisting of ground Purina Chow meal, and 
again a free intake of water. Lead (Ph) intoxication was induced by 
the addition of 1000 parts per million of the acetate [Pb(COOCH3) 2 ; 
per cent Pb = 63.71; Aldrich Chemical Co.] to the meal. Calcium and 
phosphate carriers were also added to the diet in 1.1% and 1.0% 
amounts respectively. All animals were maintained on this diet for 
the entire two week experimental period. The animals were then divided 
into four groups and kept on the aforementioned lead, calcium, and phos-
phate diet for a period of seven days. 
B. EXPERIMENTAL PROTOCOL 
The treatment for the four groups was as follows; 
1. One animal was selected from each group immediately 
prior to the administration of the test drugs for 
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blood samples in order to determine pre-injection 
levels of calcium, phosphate, and lead. Blood 
samples (10 ml each) were obtained by cardiac 
puncture and the ca++ and Pi were determined by 
SNA- 12/80, and the Pb by the dithizone urinalysis 
method modified for blood analysis (Race, 1978). 
Those rats surviving were no longer used in this 
investigation. 
2. Exactly 1 week following placement of the anlinals 
on the lead-intoxicating diet, on which they were 
maintained through the remainder of the study, in-
jections were begun: 
Group 
Group I 
Group II 
Group III 
Group IV 
Table II-1 
Experimental Groups 
No. of Rats 
6 
6 
6 
6 
Drugs 
Controls ~ 2.0 ml 0.9% 
saline 
Parathyroid Hormone (Lilly)-
2.0 ml(l ml = 100 USP units) 
Hydro-Cortisone acetate (Cal-
Biochem-Behring) - 2.0 ml 
(1 ml = 2.5 mg) 
1 ml 
1 ml 
Parathyroid Hormone plus 
Hydro-Cortisone acetate 
All drugs were administered via intraperitoneal injection 
on days 1,3,5, and 7. Each animal was weighed on day 1 
before the administration of the test drugs for its group 
and at the end of day 8 which marked the termination of 
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the experimental period. Prior to sacrificing, one animal 
was selected from each group from which blood samples were 
again obtained for ca++, Pi, and Pb determinations. 
C. POST MORTEM PREPARATION OF STUDY SPECI}illNS 
Sacrificing consisted of etherization in a large glass desic-
cator followed by pneumothorax. Immediately following sacrificing, 
surgical dissection was used to obtain tissue samples: 
1. Alveolar process - buccal to mandibular first molar 
2. Condyle of the mandible 
3. Fourth rib 
4. Femur (head) 
All soft tissue attachments were manually removed, and the formentioned 
specimen placed in 10% neutral formalin for fixation and storage for a 
period of 90 days. Following fixation, the specimens were rinsed several 
times with distilled water and then placed in a 5% H2so4 solution con-
taining 5% Na2 S04, for decalcification (Gomori, 1952) for a period of 
3 weeks. The decalcified samples were removed from this solution, 
rinsed with distilled water and then embedded in paraffin for sectioning 
and staining. 
D. STAINING PROCEDURES 
a. Hematoxylin and eosin 
b. Rhodizonate (method for lead salts) 
Sections were placed in a 0.2% solution of sodium rhodizonate 
(Sigma) in 1% acetic acid for 60 minutes, then counter stained 
with 0.1% light green S.F. in 1% acetic acid for 30 seconds. 
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All sections were permanently mounted and subjected to light micro-
scopic study and evaluation which is reported and discussed in subse-
quent chapters. 
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CHAPTER III 
RESULTS 
A. HEIGHT DATA 
Upon receiving the twenty-eight experimental animals they were 
divided into four groups, each group containing seven rats, After the 
one week acclimation period the rats were placed on the experimental 
diet as described in Chapter II: Materials and Hethods. At the end of 
seven days, each rat was weighed, blood samples were taken from one rat 
in each group, and the administration of the experimental drugs was 
begun. Sacrificing took place at the end of one week and prior to this 
weight determinations were again made on the animals. Pre and post-in-
jection weights are recorded in table III-1. 
It can be seen that the animals in Group I (saline administered 
controls) experienced an average gain in weight of 11.5 grams. Rat no. 
5 was the only animal in this group to lose weight, and this amount was 
negligible (1 gram) . The rats in Group II who received 200 USP units of 
parathyroid hormone every other day only realized an average weight gain 
of 3.8 grams. The experimental animals in Group III receiving 5 mg of 
hydrocortisone per injection and Group IV, the parathyroid hormone and 
hydrocortisone group, experienced average weight losses of 2.5 and 23.5 
grams respectively. 
B. BLOOD CHEMISTRY DATA 
Blood samples (10 ml each) were taken from one rat in each group 
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Table III-1 
Weight (grams) 
Rat 1 Rat 2 Rat 3 Rat 4 Rat 5 
pre post pre post pre post pre post pre post 
Group I 204 229* 266 278 240 253 259 273 311 310 
(saline) 
Group II 233 245* 240 261 228 244 263 252 248 223 
(PTH) 
Group III 234 262* 269 246 208 207 209 211 229 221 
(Hydrocortisone) 
Group IV 210 194* 256 242 260 235 203 170 268 244 
(PTH + Hydro-
cortisone) 
* Rats used for blood samples via cardiac puncture (see table III-2) 
Rat 6 
pre post 
227 233 
298 308 
229 216 
251 222 
Rat 7 
pre post 
269>'< 
-
174>'< 
-
275"1< 
-
295* -
Average 
gain/loss 
+ 11.5 
+ 3.8 
- 2.5 
- 23.5 
t-' 
1.0 
at random prior to the experimental injections, and then prior to sacri-
fice. The data collected from these animals (indicated in table III-1) 
selected for serum analyses of calcium (Ca++), inorganic phosphate (Pi), 
and lead (Pb) can be visualized in table III-2. 
A marked difference can be seen between the pre and post-injection 
blood levels of Pb: pre-injection levels averaged 9.2 ~g per 100 ml 
serum, while post injection levels averaged 36.4 ~g per 100 ml serum; 
a difference of 27.2 ~g %. 
Pre-injection levels of calcium in all the experimental animals 
averaged 11.88 mg per 100 rnl serum. The serum calcium level of the 
animal in Group I remained, for all practical purposes, unchanged (aver-
aged 10.8 mg %) throughout the whole of the experimental period. The 
rat from Group II demonstrated a slightly elevated calcium level from 
12.5 mg per 100 ml serum to 13.85 mg per 100 ml serum (averaging the 
two post-injection measurement levels) representing a slight gain of 
1.35 mg %. The rat from Group III (hydrocortisone), however, showed an 
increased serum calcium level of 2.6 mg % which was 1.25 mg per 100 ml 
of serum greater than the final value obtained from the PTH injected 
animal. Finally, the measured values obtained from the Group IV rat 
were as follows: pre-injection= 13.0 mg %; post~injection = 16.88 mg %. 
This demonstrates a difference of 3.88 mg per 100 ml of serum which 
proved to be 3.02 mg greater than the Group II rat and 3.45 mg greater 
than the Group III rat (post-injection levels). 
Pre-injection inorganic phosphate levels of all animals averaged 
4.6 mg per 100 ml of serum. The pre and post-injection levels of Pi 
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Table III-2 
Blood Analysis 
(~g % Ph - mg % ca++ and Pi) 
Ph ca++ pi 
Group I pre post pre post pre- post 
(Saline) 10.5 30.5 11.2 10.45 3.8 3.30 
Group II 
(PTH) 8.6 38.3 12.5 13.20- 5.6 1.05-
14.50 1.10 
Group III 
(Hydrocortisone) 5.5 32.6 10.8 12.80- 3.9 4.05 
14.05 4.25 
Group IV 
(PTH +Hydrocortisone) 12.2 44.2 13.0 16.85- 5.2 1.02 
16.90 
for the Group I rat remained essentially unchanged; 3,8 mg % and 3.3 
mg % respectively. The Group II rat showed a difference of 4.5 mg %, 
representing a loss of phosphate when compared to the pre-injection 
level, which was 2.23 mg% less than that of Group I. The Group III 
rat showed little or no change from its pre-injection level of 3.9 mg 
per 100 ml serum to its post-injection level of 4.15 mg per 100 ml 
serum, a difference of only +0.25 mg %. Finally, the Group IV (PTH-
cortisol) rat, whose pre-injection serum Pi level was 5,2 mg % re-
alized a post-injection 4.2 mg % difference to 1.02 mg per 100 ml of 
serum. 
C. HISTOLOGIC DATA 
Lead intoxication as demonstrated by the high blood levels was 
verified by the red staining of the insoluble lead salts intranuclearly 
with the sodium rhodizonate (Figures III-1 and III-2), The strength of 
staining may be compared to Figures III-3 and III-4 where the lead of 
the pencil tip markings identifying the slide were allowed to leach onto 
the tissue sections during the staining process. The resultant speci-
mens stained a deep scarlet red. The light green S.F. counterstain com-
pletely masked the rhodizonate staining of the lead salts as demonstrated 
in Figures III-5 and III-6. 
The hematoxylin and eosin stained sections of alveolar process and 
head of the femur were unremarkable. However, the rib and condyle his-
tologic sections showed some differences between the four groups. 
The PTH injected animals (Group II) showed a widening of the band 
of calcifying cartilage and zone of hypertrophy. There was also an in-
crease in the number of cartilage columns and an increase in the marrow 
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space cellularity with a concomitant decrease in the amount of calcifi-
cation and ossified structures. This may be visualized in Figures 
Ill-10, III-11, and Ill-12. The lead intoxicated saline controls by 
comparison appear in Figures III-7, III-8, and III-9. Cortisol therapy 
in the Group III rats (Figures III-13, III-14, III-15, and III-16) 
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caused a marked thinning of the proliferative (calcifying) and hyper-
trophic cartilage in the rib and condyle. The cartilage columns ap-
peared encased in the ossifying matrix. There was also decreased ossifi-
cation. In Group IV where the rats received PTH and cortisol the sec-
tions approached a medium between the controls and the PTH group. There 
was less calcification and there was a slight increase in the marrow 
space cellularity as compared to the controls. These changes are illus-
trated in Figures III-17, III-18, and III-19. 
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Figure III-1 Sodium rhodizonate stain - rib 
lOOX 
25 
Figure III-2 Sodium rhodizonate stain - head of femur 
lOOX 
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Figure III-3 Lead leaching from pencil markings 
onto tissue sections alveolar process 
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Figure III-4 Lead leaching from pencil markings onto 
tissue sections - alveolar process 
lOOX 
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Figure III-5 S.F. counterstain - rib 
lOOX 
29 
Figure III-6 S.F. counterstain- he ad of femur 
lOOX 
30 
Figure III-7 Group I - saline control - rib 
lOOX 
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Figure III-8 Group I - saline control - rib 
200X 
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Figure III-9 Group I - saline control - condyle 
lOOX 
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Figure III-10 Group II - PTH - rib 
lOOX 
34 
Figure III-11 Group II - PTH - rib 
200X 
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Figure III-12 Group II - PTH - condyle 
lOOX 
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Figure III-13 Group III - Cortisol - rib 
lOOX 
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Figure III-14 Group III - Cortisol - rib 
lOOX 
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Figure III-15 Group III - Cortisol - rib 
200X 
39 
Figure III-16 Group III - Cortisol - condyle 
lOOX 
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Figure III-17 Group IV - PTH + Cortisol - rib 
lOOX 
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Figure III-18 Group IV - PTH + Cortisol - rib 
200X 
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Figure III-19 Group IV - PTH + Cortisol - condyle 
lOOX 
CHAPTER IV 
DI SCUSSION 
While t he in i tial thrust of this investigation was to study the 
effec t s o f cortis ol and parathyroid hormone (PTH), alone and in com-
bina tion with each other, on bone in the lead intoxicated albino rat, 
t wo a r eas , initially assigned minor importance, surfaced >.Jith some in-
t e r esting r esults. One area deals with the we ight of the animals, and 
the other is rela ted to serum levels of calcium (ca++-), phosphate (Pi), 
and lead (Pb) . 
Da ta reflecting weight changes is reported in Table III-1, where 
the controll e d Group I demonstrated a mean increase in weight of 11.5 
grams. This r epresents only a 4.4% increase over the ir initial weights. 
Group II, those animals receiving PTH, shmved a weight ga in of only 1.5% 
of their initial mea n value; the ir actual mean increase was 3.8 g rams. 
In terms of weight gain or los s , Groups III and IV faired worse than 
those in Groups I and II, in fact the former lost weight. Group III, 
those receiving cortisol, lost an average of 2.5 grams, which is not 
considera bly g r eat when compared to 23.5 gram loss demonstrated by 
Group IV, who received the combined PTH-cortisol injections. The data 
from Gr oups III a nd IV is not inconsistent with that reported in the 
lit e r a tur e . According to Bernick and Ershoff (1963), the administra -
tion of cort isone to r a t s r esults in a reduction in food intake by 
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these animals, and negative nitrogen balance. Earlier, Bavetta, Ber-
nick, and Ershoff (1959) maintained rats on a qualitatively adequate 
diet which was limited to approximately 5 grams per day. They were 
able to show that these rats fed this low caloric diet did not neces-
sarily lose weight, but had their weights plateau. 
Comparatively, the animals in Groups I and II (saline controls 
and PTH injected rats, respectively) did show a little gain in weight 
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of +11.5 grams and +3.8 grams respectively. They were allowed food and 
water freely, and should have shown greater weight gains than those ob-
served. However, it should be reiterated at this point that their ground 
Purina Fox Chow food was adulterated with lead acetate (Pb=lOOO ppm), 
1.1 percent Ca, and 1.0 percent Pi after the manner of Hsu, Krook, and 
Pond (1973). The ingestion of the heavy metal Pb might account for 
this almost catabolic effect with respect to their weights. One of the 
numerous symptoms of chronic lead poisoning is anorexia, which perhaps 
helps to explain the lack of weight gain in the first two groups. 
Upon analyzing the data obtained from pre and post-injection blood 
samples, tested for ca++, Pi• and Pb, it was of interest to note that 
the pre-injection blood levels of ca++ and Pi were all within their nor-
mal ranges (ca++, mean= 11.8 mg/100 ml serum; Pi, mean = 4.8 mg/100 ml 
serum). On the other hand, pre-injection Pb values appeared to be rel-
atively inconsistent (see Table III-2) with a mean value of 9.2 ~g/100 
ml serum which, according to Berkow (1977), appears to be insignifi-
cantly low, and relative to human beings, low enough not to be toxic 
(normal non-toxic human level 15 to 40 ~g %) . While these values appear 
to be low, it should be pointed out that these animals had only been 
exposed to the lead in their diet for a period of only one week, a time 
period certainly not long enough to be considered toxic, However, at 
the end of the experimental period, the serum Pb values had increased 
by some 76 percent over their original values, putting the animals at 
the lower limits of chronic lead intoxication. In the beginning of 
this study, it appears obvious that the low borderline toxic levels of 
Pb had little or no effect on serum ca++ or Pi levels in all groups, 
especially Group I rats. Group II animals receiving PTH demonstrated 
a rise in serum ca++ of 1 to 2 mg over their pre-injection levels, but 
a fall of approximately 4.5 mg of Pi compared to the pre-injection 
levels. These effects of parathyroid hormone on ca++ and Pi are well 
known and consistent with the literature with the exception of the very 
slight hypercalcemia, observed in this group, which is believed to be 
due to suppression of mobilization of ca++ from bone due to the pre-
sence of low, toxic Pb concentrations. 
The animals in Group III receiving cortisol demonstrated a rise 
in serum ca++ to the order of 2.85 mg %, representing a 20 percent in-
crease over their pre-injection level. However, there was no apprecia-
ble difference between pre-injection and post-injection levels of Pi. 
While this data is somewhat in agreement with the literature, one can-
not help but feel that the presence of Pb might have prevented some 
dramatic disclosures in this group of animals. 
Finally, Group IV rats receiving PTH and cortisol do show some 
dramatic differences between pre and post-injection levels of ca++ and 
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Pi. This group demonstrated a marked increase in Ca++ levels to the 
order of 22.8 percent higher than its pre-injection levels, and slight-
ly higher than the post-injection levels of Groups II and III (3.02 mg 
and 3.22 mg respectively). The observation that the post-injection ca++ 
concentration of 16.87 mg per 100 ml serum was higher in Group IV than 
the post-injection level of Group II which was observed to be 13.85 mg 
per 100 ml serum can only be explained on the basis of the presence of 
the Pb. According to Bentzel, Carbone, and Rosenberg (1964), Lazor and 
Rosenberg (1964), and Mundy and Raisz (1974) glucocorticoids have been 
shown to be effective in the treatment of hypercalcemia associated with 
hematological neoplasms, however, their mechanism of action remains un-
defined to any real degree of satisfaction (Strumpf, Kowalski, and 
Mundy 1978). The post-injection Pi level, while markedly lower than 
the pre-injection level (4.18 mg), was almost identical to the pre and 
post-injection levels of Group II. 
Upon reflecting, one cannot help but to consider the presence of 
Pb to be a factor responsible for the results obtained relative to the 
weights of the animals, their serum ca++ and Pi levels, and even the 
changes in Pb levels under the influence of PTH, cortisol, and PTH + 
cortisol. Earlier chronic Pb studies, ranging from 9 to 20 weeks, al-
lowed time for the toxic effects of the heavy metal to set in, while the 
basic idea in this study was to have a low grade of toxicity develop 
over a very short period of time (2 weeks) in order to see if this "sub-
liminal" toxicity had a greater or lesser effect in the areas under 
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investigation. The number of bizarre findings in this study are quite 
intriguing and suggests further extension of this study relative to the 
use of larger and varying doses of both PTH and cortisol; extension of 
the time of lead exposure prior to, and/or during administration of the 
hormones. A final avenue would include: samples of epiphyses of long 
bones, ribs, and sections of liver and kidney. The use of rhodizonate 
should not be abandoned, but the manner of decalcification of hard tis-
sue should be further investigated due to the presence of artifacts in 
the specimens possibly caused by the use of sulfuric acid. As reported 
by Pearse (1960) the rhodizonate method is quite sensitive for lead: 
"In practice I have found that small concentrations of an insoluble 
lead salt (PbS04) in the tissues can readily be demonstrated by the rho-
dizonate method." These insoluble lead salts are transformed from solu-
ble Pb deposits in the bone by the decalcification procedure utilizing 
(Gomori, 1952). 
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Histologically, the results in this experiment are consistent with 
past literature. Group II, the PTH injected animals, showed a decrease 
in the amount of calcification in growth areas (rib and condyle). As 
reported by Yonaga (1978) on sections of rat proximal tibia sections, 
the rib and condyle sections of Group II showed a widening of the car-
tilaginous plate and a widening of the hypertrophic cell layer. There 
was also increased cellularity in the marrow spaces with a decrease in 
ossification. Laron, Muhlethaler, and Klein (1958) reported that para-
thyroid extract produces changes expected from excess parathyroid hormone. 
There was interference with normal calcification and hypercalcemia. 
The Group III histologic studies also concurred with past refer-
ences (Follis, 1951; Sissons and Hadfield, 1955; Laron, Muhlethaler, 
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and Klein, 1958; Bernick and Ershoff, 1963; Jee, Park, Roberts, and 
Kenner, 1973). There was a narrowing of the cartilaginous growth zones 
(rib and condyle) and an encasement of the cartilage columns in the os-
sifying matrix. There was also a decrease in the amount of calcifica-
tion taking place. It seemed that the whole process of cartilage chang-
ing into mature bone was at a standstill. As Bernick and Ershoff re-
ported in 1963, "one may conclude that cortisone, by its action upon the 
acid mucopolysaccharides, alters the ground substance of bone, thus in-
hibiting its proper calcification, its physiologic resorption and, there-
fore, its reorganization". 
This reduction in bone activity is time and dose dependent as re-
ported by Jee, Park, Roberts, and Kenner in 1973. Low doses of cortisol 
(1 and 5 mg/kg/day) reduce bone through increased bone resorption and 
high doses (20 and 75 mg/kg/day) depress bone resorption in rats. Also 
noted by Roberts in 1969 was that at the high dose levels of cortisol, 
progenitor cell proliferation and bone formation were depressed without 
any evidence of increased resorption of bone, and at low doses the cor-
ticosteroid action was characterized by increased progenitor cell pro-
liferation, increased number of osteoclasts, and increased resorption 
of bone. The histology presented by the rats in Group III is consistant 
with the data presented by Roberts. The rats in Group III received 5 
mg every other day for seven days. The average weight of the rats over 
the experimental period was approximately 250 grams, therefore, the 
dose averaged out to 20 mg/kg/injection, which according to the pre-
vious studies would appear on the low end of the high dose level spec-
trum. Sissons and Hadfield (1955) reported a retardation of bone 
growth and organization with this "high" dose of cortisol. 
When both hormones were given simultaneously the results obtained 
histologically demonstrated an antagonistic action between cortisol and 
PTH. The blood chemistry levels do not verify this but, again, this 
may be due to the presence of Pb which has an osteolytic effect upon 
bone. The dosage of cortisol plays an important role here. As report-
ed by Roberts (1969) at low doses cortisol induces a secondary hyper-
parathyroidism which results in increased bone resorption. In this case, 
the effect of exogenous and endogenous PTH would be cumulative. At the 
higher doses though, the inhibitory effect of the corticosteroid takes 
precedence and the hormonal antagonism occurs, This resultant minimal 
PTH effect was evident in the Group IV rats. 
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SUMMARY AND CONCLUSIONS 
The data obtained during this study showed a definite effect on 
ca++ and Pi metabolism as reflected by the serum studies on all of the 
animals treated with PTH, cortisol, and PTH + cortisol, some consistent 
with the prevailing literature in the presence of a lead intoxication 
of a very low grade. The weights of the test animals were affect like-
wise: although subtle (possibly due to the time and dosage parameters), 
histologic changes in bone also occurred. Relative to the few incon-
sistencies noted between the data presented in this paper and the past 
literature, the low lead dose and time exposure as well as the doses of 
the hormones administered may have had an effect. These experiments 
should be extended and further investigations undertaken in the manner 
suggested in Chapter IV. 
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